CTCAE v6 Readiness · Available

Before implementing CTCAE v6, know what changes and where it matters.

MedOncNORD assesses the operational impact of CTCAE v6.0 on the study and system materials within scope, including terminology, grading, mappings, eCRFs, EDC specifications and safety workflows, so relevant changes can be identified before configuration or go-live.

Released22 July 2025
StandardNCI CTCAE v6.0
TerminologyMedDRA 28.0
Transition resourceOfficial v5.0 → v6.0 mapping available
Why readiness matters

A terminology change can propagate through an entire study workflow.

CTCAE terminology and grading can be reflected across study specifications, eCRFs, EDC configuration, mappings, clinical safety processes, testing and downstream documentation.

Not every CTCAE v6 change will affect every study or system.

The challenge is identifying which changes matter in the relevant study and system context, before teams modify too much, too little or too late.

  1. 01

    Which CTCAE v6 changes are actually relevant to our studies and systems?

  2. 02

    Where do those changes propagate into forms, mappings, configuration or workflows?

  3. 03

    What needs to change, what can remain as is and what should be tested before go-live?

Impact pathway

The objective is not to rewrite your systems. It is to identify what matters before implementation begins.

  1. ChangeCTCAE v6 change
  2. SpecificationStudy / safety specification
  3. Data captureeCRF · EDC · mappings
  4. WorkflowClinical safety workflow
  5. ActionImplementation / testing

Not every change affects every layer. The assessment follows only the touchpoints relevant to the agreed scope.

What you receive

CTCAE v6 Readiness Brief

A focused assessment showing which CTCAE v6 changes are relevant to the agreed scope, where they affect existing materials or workflows, and what should happen before implementation.

01

Relevant changes

The CTCAE v6 terminology, grading or mapping differences that matter within the agreed study or system scope.

02

Impact view

The documents, forms, configuration points, mappings or workflow touchpoints affected by those changes.

03

Priority actions

What requires update, clarification or implementation review and what can remain unchanged.

04

Test cases

Prioritised synthetic cases for relevant grading, data capture or workflow changes where testing is included in scope.

Impact assessment · terminology & mapping review · eCRF / EDC review · priority action list · synthetic test cases where applicable

Change what needs changing. Leave the rest alone.

A readiness assessment is intended to prevent unnecessary rework while making relevant CTCAE v6 impacts visible before study materials or system changes reach production.

What can be reviewed
  • Terminology & gradingRelevant changes in adverse-event terms, definitions and grade criteria.
  • MappingsRelevant v5.0 → v6.0 term and grade relationships and their implications for existing materials.
  • Data captureeCRFs, EDC specifications or study documents that reference affected CTCAE content.
  • Clinical safety workflowOperational touchpoints where terminology or grading changes affect review, data handling or downstream processes.
Decision points

Useful before CTCAE changes reach production.

  • Before a new study buildWhen CTCAE v6.0 is being incorporated into a new protocol, eCRF or EDC specification.
  • Before updating existing templatesWhen reusable study or clinical safety materials need to be reviewed against v6.0.
  • Before configuration goes liveWhen terminology, grading or mapping changes are moving from specification into implementation.
  • When teams need one agreed impact viewWhen clinical, data management, safety and implementation teams need a shared, prioritised view of what changes.
Engagement

Defined scope. Existing materials. Actionable output.

  1. You provide

    The relevant materials within scope, for example CTCAE-related study specifications, eCRFs, mappings, EDC documentation or clinical safety workflow materials.

  2. We agree

    Studies, systems, documents, scope, deliverables, timing and fee before the review begins.

  3. We deliver

    A CTCAE v6 Readiness Brief with relevant impacts, prioritised actions and test cases where included in scope.

  • No patient-level data required for a standard readiness assessment
  • Existing study / system materials
  • Defined scope
  • NDA · data processing agreement where applicable
  • Fixed scope and fee agreed upfront
Designed for

Clinical Operations · Clinical Data Management · Clinical Safety / Safety Operations · Oncology biotech study teams · CRO / implementation teams where relevant

MedOncNORD identifies and prioritises CTCAE v6 impacts within the agreed scope. Sponsor-specific implementation decisions, system configuration and formal validation remain with the responsible sponsor and implementation teams unless separately agreed.

CTCAE v6 Readiness

Know the impact before implementation.

For oncology teams preparing a new study build, updating existing materials or determining where CTCAE v6.0 affects study, data and clinical safety workflows.

Contact

Contact MedOncNORD

For ONCOTrack clinical pilot discussions, oncology development projects, CTCAE v6 assessments or qualified investment conversations.

Email MedOncNORD info@mednord.se · We reply within two business days.
Phone +46 73 731 37 34 Office Gunnarbovägen 80, 170 61 Solna

We use the details you submit to respond to your enquiry. See our Privacy Notice.